Search

Your search keyword '"L Palmqvist"' showing total 92 results

Search Constraints

Start Over You searched for: Author "L Palmqvist" Remove constraint Author: "L Palmqvist"
92 results on '"L Palmqvist"'

Search Results

1. Toward a standard approach to measurement and reporting of perioperative mortality rate as a global indicator for surgery

2. Use and definitions of perioperative mortality rates in low-income and middle-income countries: a systematic review

Catalog

Books, media, physical & digital resources

3. High-frequency impacts in a converter-based back-to-back tie; the eagle pass installation

4. No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

5. Monitoring and evaluating surgical care: defining perioperative mortality rate and standardising data collection

6. Impacts of high-frequency voltage on cable-terminations with resistive stressgrading

7. Electrical properties of field grading materials influenced by the silicon carbide grain size

8. Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13).

9. 'To have a plan': teachers' perceptions of working with a literacy instruction combining phonics and comprehension applications for students with intellectual disability and communication difficulties.

10. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).

11. The potential impact of literacy intervention on speech sound production in students with intellectual disability and communication difficulties.

12. Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation.

13. Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia.

14. The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.

15. Dog Owners' Perceptions of Canine Body Composition and Effect of Standardized Education for Dog Owners on Body Condition Assessment of Their Own Dogs.

16. Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia.

17. Implementing precision medicine in a regionally organized healthcare system in Sweden.

18. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.

19. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias.

20. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).

21. Parents act as intermediary users for their children when using assistive technology for cognition in everyday planning: Results from a parental survey.

22. ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.

23. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.

24. Cognitive abilities and life experience in everyday planning in adolescents with intellectual disabilities: Support for the difference model.

25. International external quality assurance of JAK2 V617F quantification.

26. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML.

27. Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.

28. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.

29. Role of NOX2 for leukaemic expansion in a murine model of BCR-ABL1 + leukaemia.

30. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.

31. The aldehyde dehydrogenase cord blood potency assay excludes early apoptotic cells.

32. Concentration of the CDCP1 protein in human cord plasma may serve as a predictor of hematopoietic stem and progenitor cell content.

33. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.

34. Improved MPL mutation screening with multiplex PCR and capillary electrophoresis.

35. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.

36. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.

37. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.

38. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.

39. MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.

40. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.

41. Mutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia.

42. p27(KIP1) and PTEN cooperate in myeloproliferative neoplasm tumor suppression in mice.

43. Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.

44. Molecular diagnostics of myeloproliferative neoplasms.

45. The effectiveness of working memory training with individuals with intellectual disabilities - a meta-analytic review.

46. Exploring the heterogeneity of the hematopoietic stem and progenitor cell pool in cord blood: simultaneous staining for side population, aldehyde dehydrogenase activity, and CD34 expression.

47. Wild-type KRAS inhibits oncogenic KRAS-induced T-ALL in mice.

48. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.

49. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.

50. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.